Speakers
Melissa Jones has over a decade of experience in drug development for ophthalmology, working both in developing novel therapeutics at the bench and in clinical…
Read MoreDr. Bill Maughan is a seasoned equity research leader with deep expertise in biotechnology, oncology, ophthalmology, and genetic medicine. He earned his Ph.D. in Biochemistry,…
Read MoreMilton M. Hom, OD, FAAO, is a Los Angeles-area optometrist and internationally recognized clinician-researcher whose work spans therapeutics, dry eye disease, presbyopia, contact lens technology…
Read MoreMr. Culley joined Lineage as Chief Executive Officer in September 2018 and served as Interim Chief Financial Officer from January 20, 2021 to June 21,…
Read MoreAsh Kras is a retina specialist, Fulbright scholar and Harvard-trained bioinformatician specialized in interoperability and clinical AI. He is also the founder and CEO of…
Read MoreGordon Bethwaite is a seasoned ophthalmic industry executive with 25 years of global leadership across start-ups, commercial stage companies, and major players in vision care.…
Read MoreEvert “Eef” Schimmelpennink has served as LENZ’s President and Chief Executive Officer and a member of the LENZ board of directors since March 2021. Previously,…
Read MoreReza Safaei, MD, serves as Vice President and Head of Medical Affairs International at Apellis Pharmaceuticals, where he leads global medical strategy across key therapeutic…
Read MoreDr. Vinit Mahajan is a Professor of Ophthalmology at Stanford University and an internationally recognized vitreoretinal surgeon-scientist. He directs the NIH-funded Molecular Surgery and Omics…
Read MoreAlex Lopez, Chief Commercial Officer for Ace Vision Group, boasts over two decades of leadership and commercial experience in ophthalmology and aesthetics markets. Renowned for…
Read MoreBiren Amin is a managing director and senior research analyst on the healthcare equity research team covering biotechnology companies. Prior to joining Piper Sandler, Amin…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
